Source: EBioMedicine [EBioMedicine] 2024 May; Vol. 103, pp. 105100. Date of Electronic Publication: 2024 Apr 24.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients.

Authors : Massa F; Department of Nephrology, Dialysis and Transplantation, Pasteur 2 Hospital, Nice University Hospital, 30 voie Romaine, 06300, Nice, France; Laboratory of Molecular Physio Medicine, University Côte d'Azur, CNRS, 28 Avenue de Valombrose, 06107, Nice, France

Subjects: Kidney Transplantation*; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology SARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2021 Nov; Vol. 73, pp. 103679. Date of Electronic Publication: 2021 Nov 08.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.

Authors : Groß R; Institute of Molecular Virology, Ulm University Medical Center, 89081, Ulm, Germany.; Zanoni M

Subjects: Immunization, Secondary*; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*administration & dosage SARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2022 Jan; Vol. 75, pp. 103761. Date of Electronic Publication: 2021 Dec 17.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers.

Authors : Moncunill G; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain; CIBER de Enfermedades Infecciosas, Madrid, Spain. Electronic address: .

Subjects: Health Personnel*; 2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/2019-nCoV Vaccine mRNA-1273/*administration & dosage ; Antibody Formation/Antibody Formation/Antibody Formation/*drug effects

Source: EBioMedicine [EBioMedicine] 2022 Jan; Vol. 75, pp. 103805. Date of Electronic Publication: 2022 Jan 12.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Mucosal immune response in BNT162b2 COVID-19 vaccine recipients.

Authors : Azzi L; Azienda Socio-Sanitaria Territoriale dei Sette Laghi, Department of Medicine and Surgery, University of Insubria, Varese, Italy. Electronic address: .; Dalla Gasperina D

Subjects: Immunization, Secondary*; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*immunology

Source: EBioMedicine [EBioMedicine] 2022 Jan; Vol. 75, pp. 103788. Date of Electronic Publication: 2021 Dec 23.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Editorial & Opinion

What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?

Authors : Silvestris N; Medical Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, 70124 Bari, Italy; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', 70124 Bari, Italy. Electronic address: .

Subjects: Immunity* ; Immunocompromised Host*; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology

Source: EBioMedicine [EBioMedicine] 2021 Dec; Vol. 74, pp. 103733. Date of Electronic Publication: 2021 Dec 01.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Influence of past infection with SARS-CoV-2 on the response to the BNT162b2 mRNA vaccine in health care workers: Kinetics and durability of the humoral immune response.

Authors : Ontañón J; Immunology Unit, Albacete General Hospital, c/ Hermanos Falcó 37, E-02008 Albacete, Spain.; Blas J

Subjects: Immunity, Humoral*; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology ; COVID-19/COVID-19/COVID-19/*pathology

Source: EBioMedicine [EBioMedicine] 2021 Nov; Vol. 73, pp. 103656. Date of Electronic Publication: 2021 Oct 30.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Differences in SARS-CoV-2 specific humoral and cellular immune responses after contralateral and ipsilateral COVID-19 vaccination.

Authors : Ziegler L; Department of Transplant and Infection Immunology, Saarland University, Germany.; Klemis V

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

Source: EBioMedicine [EBioMedicine] 2023 Sep; Vol. 95, pp. 104743. Date of Electronic Publication: 2023 Aug 11.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study.

Authors : Altarawneh HN; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Hepatitis D*; Humans SARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2023 Sep; Vol. 95, pp. 104734. Date of Electronic Publication: 2023 Jul 27.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV - a prospective observational cohort study.

Authors : Heftdal LD; Viro-Immunology Research Unit, Department of Infectious Diseases, Section 8632, University of Copenhagen, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark; Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Oe, Denmark

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; HIV Infections*; Humans

Source: EBioMedicine [EBioMedicine] 2023 Jul; Vol. 93, pp. 104661. Date of Electronic Publication: 2023 Jun 16.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine.

Authors : Azzi L; Azienda Socio-Sanitaria Territoriale dei Sette Laghi, Department of Medicine and Surgery, University of Insubria, Varese, Italy.; Dalla Gasperina D

Subjects: Immunity, Mucosal* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

Source: EBioMedicine [EBioMedicine] 2023 Feb; Vol. 88, pp. 104435. Date of Electronic Publication: 2023 Jan 09.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.

Authors : Alexander JL; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom; Department of Gastroenterology and Hepatology, Imperial College Healthcare NHS Trust, London, United Kingdom. Electronic address: .

Subjects: Gastrointestinal Microbiome* ; COVID-19* ; Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/drug therapy

Source: EBioMedicine [EBioMedicine] 2023 Feb; Vol. 88, pp. 104430. Date of Electronic Publication: 2023 Jan 10.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study.

Authors : Fong CH; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.; Zhang X

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*SARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2023 Feb; Vol. 88, pp. 104446. Date of Electronic Publication: 2023 Jan 25.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees.

Authors : Van Coillie J; Fatebenefratelli-Sacco Infectious Diseases Physicians group; UMC COVID-19 S3/HCW study group;

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

Source: EBioMedicine [EBioMedicine] 2023 Jan; Vol. 87, pp. 104408. Date of Electronic Publication: 2022 Dec 16.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.

Authors : Madhavan M; Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford OX3 7BN, UK; Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford OX3 7LE, UK.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Viral Vaccines*; Adult

Source: EBioMedicine [EBioMedicine] 2022 Nov; Vol. 85, pp. 104298. Date of Electronic Publication: 2022 Oct 10.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2.

Authors : Vogel E; Institute of Virology, School of Medicine, Technical University of Munich / Helmholtz Zentrum München, Trogerstr. 30, 81675 München, Germany.; Kocher K

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Viral Vaccines*; Humans

Source: EBioMedicine [EBioMedicine] 2022 Nov; Vol. 85, pp. 104294. Date of Electronic Publication: 2022 Oct 04.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.

Authors : Aggarwal A; The Kirby Institute, University of New South Wales, New South Wales, Australia.; Akerman A

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics; Angiotensin-Converting Enzyme 2/Angiotensin-Converting Enzyme 2/Angiotensin-Converting Enzyme 2/genetics SARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2022 Oct; Vol. 84, pp. 104270. Date of Electronic Publication: 2022 Sep 18.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study.

Authors : Seery V; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS). Facultad de Medicina. UBA-CONICET, Paraguay 2155, C1121ABG Caba, Argentina.; Raiden S

Subjects: COVID-19* ; SARS-CoV-2*; Adult SARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2022 Sep; Vol. 83, pp. 104230. Date of Electronic Publication: 2022 Aug 18.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.

Authors : Wilhelm A; Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, 60596 Frankfurt am Main, Germany.; Widera M

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy ; Viral Vaccines*; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/therapeutic use SARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2022 Aug; Vol. 82, pp. 104158. Date of Electronic Publication: 2022 Jul 11.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants.

Authors : Chang MR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, United States.; Ke H

Subjects: COVID-19* ; Viral Vaccines*; Ad26COVS1 SARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2022 Jun; Vol. 80, pp. 104025. Date of Electronic Publication: 2022 May 06.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine.

Authors : Coléon S; Wiedemann A ...

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Viral Vaccines*; Animals

Source: EBioMedicine [EBioMedicine] 2022 Jun; Vol. 80, pp. 104062. Date of Electronic Publication: 2022 May 17.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial.

Authors : Bánki Z; Mateus J ...

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; SARS-CoV-2*; Antibodies, Neutralizing SARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2022 Jun; Vol. 80, pp. 104073. Date of Electronic Publication: 2022 May 23.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents.

Authors : Canaday DH; Case Western Reserve University School of Medicine, Cleveland, OH; Geriatric Research, Education and Clinical Center, Cleveland VA. Electronic address: .

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*; Aged COVID-19 vaccine booster shotSARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2022 Jun; Vol. 80, pp. 104066. Date of Electronic Publication: 2022 May 20.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Editorial & Opinion

Reply to the Letter to the Editor: "Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 vaccine" by Francavilla B et al.: Lack of a strong oral mucosal immune response: rethinking the route of COVID-19 vaccine boost administration?

Authors : Azzi L; Azienda Socio Sanitaria Territoriale dei Sette Laghi, Department of Medicine and Surgery, University of Insubria, Varese, Italy. Electronic address: .; Dalla Gasperina D

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*; BNT162 Vaccine

Source: EBioMedicine [EBioMedicine] 2022 May; Vol. 79, pp. 104005. Date of Electronic Publication: 2022 Apr 15.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Editorial & Opinion

Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 Vaccine.

Authors : Francavilla B; Department of Otorhinolaryngology, University of Rome 'Tor Vergata', Rome, Italy. Electronic address: .; Nuccetelli M

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*; Antibodies, Viral

Source: EBioMedicine [EBioMedicine] 2022 May; Vol. 79, pp. 104006. Date of Electronic Publication: 2022 Apr 14.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines.

Authors : Lu L; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.; Chen LL

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*; Antibodies, Blocking SARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2022 May; Vol. 79, pp. 103986. Date of Electronic Publication: 2022 Apr 08.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies.

Authors : Tada T; Department of Microbiology, NYU Grossman School of Medicine, 430 East 29th Street, Alexandria West Building, Rm 509, New York, NY 10016, USA.; Zhou H

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; SARS-CoV-2*; Antibodies, Monoclonal SARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2022 Apr; Vol. 78, pp. 103944.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print Cited Medium: Internet ISSN: 2352-3964

Record details

Read More Add to Saved list

Academic Journal

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals.

Authors : Muena NA; Laboratorio de Virología Molecular, Fundación Ciencia and Vida, Santiago, Chile.; García-Salum T

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; SARS-CoV-2*; Antibodies, Neutralizing SARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2022 Apr; Vol. 78, pp. 103972. Date of Electronic Publication: 2022 Mar 30.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals.

Authors : Ruggiero A; Piubelli C ...

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; SARS-CoV-2*; Antibodies, Viral

Source: EBioMedicine [EBioMedicine] 2022 Mar; Vol. 77, pp. 103888. Date of Electronic Publication: 2022 Feb 20.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong.

Authors : Peng Q; AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong. Hong Kong Special Administrative Region, People's Republic of China

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/geneticsSARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2022 Mar; Vol. 77, pp. 103904. Date of Electronic Publication: 2022 Mar 03.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines.

Authors : Wang Y; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), No. 31 Huatuo Street, Daxing District, Beijing 102629, China. Electronic address: .

Subjects: Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*blood ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood ; COVID-19/COVID-19/COVID-19/*prevention & control SARS-CoV-2 variants

Source: EBioMedicine [EBioMedicine] 2021 Nov; Vol. 73, pp. 103677. Date of Electronic Publication: 2021 Nov 03.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.

Authors : Sormani MP; CovaXiMS study group on behalf of the Italian Covid-19 Alliance in MS

Subjects: Antibody Formation/Antibody Formation/Antibody Formation/*drug effects ; COVID-19/COVID-19/COVID-19/*prevention & control ; COVID-19 Vaccines/COVID-19 Vaccines/COVID-19 Vaccines/*therapeutic use

Source: EBioMedicine [EBioMedicine] 2021 Oct; Vol. 72, pp. 103581. Date of Electronic Publication: 2021 Sep 22.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination.

Authors : Appelman B; van der Straten K ...

Subjects: Antibody Formation* ; COVID-19*; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood

Source: EBioMedicine [EBioMedicine] 2021 Oct; Vol. 72, pp. 103589. Date of Electronic Publication: 2021 Sep 24.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data.

Authors : Glatman-Freedman A; The Israel Centre for Disease Control, Israel Ministry of Health, Tel Hashomer, Ramat Gan, Israel; Department of Epidemiology and Preventive Medicine, School of Public Health, Tel Aviv University Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: .

Subjects: Registries*; COVID-19/COVID-19/COVID-19/*prevention & control ; COVID-19 Vaccines/COVID-19 Vaccines/COVID-19 Vaccines/*therapeutic use

Source: EBioMedicine [EBioMedicine] 2021 Oct; Vol. 72, pp. 103574. Date of Electronic Publication: 2021 Sep 17.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.

Authors : Havervall S; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.; Marking U

Subjects: Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; Antibody Formation/Antibody Formation/Antibody Formation/*immunology ; COVID-19/COVID-19/COVID-19/*immunology

Source: EBioMedicine [EBioMedicine] 2021 Aug; Vol. 70, pp. 103523. Date of Electronic Publication: 2021 Aug 12.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.

Authors : Zollner A; Christian Doppler Laboratory for Mucosal Immunology, Johannes Kepler University Linz, Linz, Austria; Department of Medicine, Division of Internal Medicine 1 (Gastroenterology and Hepatology, Endocrinology and Metabolism), Medical University of Innsbruck, Innsbruck, Austria.

Subjects: B-Lymphocytes/B-Lymphocytes/B-Lymphocytes/*immunology ; COVID-19/COVID-19/COVID-19/*immunology ; COVID-19 Vaccines/COVID-19 Vaccines/COVID-19 Vaccines/*immunology

Source: EBioMedicine [EBioMedicine] 2021 Aug; Vol. 70, pp. 103539. Date of Electronic Publication: 2021 Aug 12.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis.

Authors : Strengert M; Helmholtz Centre for Infection Research, Braunschweig, Germany; TWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany.

Subjects: COVID-19/COVID-19/COVID-19/*immunology ; COVID-19 Vaccines/COVID-19 Vaccines/COVID-19 Vaccines/*immunology ; Immunity, Cellular/Immunity, Cellular/Immunity, Cellular/*immunology

Source: EBioMedicine [EBioMedicine] 2021 Aug; Vol. 70, pp. 103524. Date of Electronic Publication: 2021 Aug 12.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Patron Login

menu

Search Results

Your Filters

Engage with CCPL

Contact CCPL